Compare Garuda Cons with Similar Stocks
Stock DNA
Construction
INR 1,435 Cr (Small Cap)
13.00
30
0.00%
-0.04
27.43%
3.65
Total Returns (Price + Dividend) 
Latest dividend: 0 per share ex-dividend date: Feb-17-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Garuda Construction and Engineering Ltd is Rated Sell
Garuda Construction and Engineering Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Garuda Construction and Engineering Ltd is Rated Sell
Garuda Construction and Engineering Ltd is rated Sell by MarketsMOJO. This rating was last updated on 10 March 2026, reflecting a change from the previous 'Hold' rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 March 2026, providing investors with the latest insight into the stock's position.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Feb-2026 | Source : BSENewspaper Advertisement publication of Standalone and Consolidated Unaudited Financial Result for the Quarter ended 31st December 2025
Outcome Of Board Meeting Held On 12 February 2026.
12-Feb-2026 | Source : BSEFinancial Results for the Quarter and Nine months ended December 31st 2025.
Board Meeting Outcome for Outcome Of Board Meeting Held On 12 February 2026.
12-Feb-2026 | Source : BSEPursuant to the provisions of Regulation 30 and 33 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations 2015) Board of Directors of the Company has approved the following: 1. Financial Results: a. Approved the Unaudited Standalone Financial Results for the Quarter ended 31 December 2025 along with Limited Review Report as received from the Statutory Auditor of the Company. b. Approved the Unaudited Consolidated Financial Results for the Quarter ended 315 December 2025 along with Limited Review Report as received from the Statutory Auditor of the Company.
Corporate Actions 
No Upcoming Board Meetings
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.59%)
Held by 7 FIIs (2.34%)
Pkh Ventures Limited (51.7%)
Yash Shares And Stock Private Limited (3.98%)
20.54%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 20.26% vs -6.95% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 21.48% vs -3.11% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 195.08% vs 124.82% in Sep 2024
Growth in half year ended Sep 2025 is 191.95% vs 113.45% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 164.86% vs 53.43% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 177.46% vs 39.97% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 45.95% vs -4.05% in Mar 2024
YoY Growth in year ended Mar 2025 is 36.66% vs -10.69% in Mar 2024







